Beam Therapeutics, Inc. (BEAM)
24.50
+0.11
(+0.45%)
USD |
NASDAQ |
Oct 02, 16:00
24.50
0.00 (0.00%)
After-Hours: 20:00
Beam Therapeutics Profit Margin (Quarterly) : -25.04K% for June 30, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -25.04K% |
| March 31, 2026 | -297.2% |
| December 31, 2025 | |
| September 30, 2025 | -1.16K% |
| June 30, 2025 | -1.21K% |
| March 31, 2025 | -1.45K% |
| December 31, 2024 | -300.5% |
| September 30, 2024 | -677.5% |
| June 30, 2024 | -773.5% |
| March 31, 2024 | -1.33K% |
| December 31, 2023 | 45.16% |
| September 30, 2023 | -558.9% |
| June 30, 2023 | -411.5% |
| March 31, 2023 | -398.5% |
| December 31, 2022 | -191.4% |
| Date | Value |
|---|---|
| September 30, 2022 | -693.6% |
| June 30, 2022 | -432.1% |
| March 31, 2022 | -820.8% |
| December 31, 2021 | -126.7% |
| September 30, 2021 | -3.69K% |
| June 30, 2021 | -1.27M% |
| March 31, 2021 | -3.36M% |
| December 31, 2020 | -1.59M% |
| September 30, 2020 | -574.2K% |
| June 30, 2020 | -570.3K% |
| March 31, 2020 | -507.6K% |
| December 31, 2019 | -464.2K% |
| September 30, 2019 | -316.8K% |
| June 30, 2019 | -297.7K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Intellia Therapeutics, Inc. | -1.39K% |
| Twist Bioscience Corp. | -29.61% |
| Prime Medicine, Inc. | -3.65K% |
| Q32 Bio, Inc. | -- |
| Sarepta Therapeutics, Inc. | -1.22% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -7.79% |
| Return on Assets | -6.06% |
| Return on Invested Capital | -6.63% |
| Gross Profit Margin (Quarterly) | -1.00K% |
| Operating Margin (Quarterly) | -25.83K% |
| Return on Net Operating Assets | -42.23% |